[#item_full_content] Net revenue rose to $320.6M in FY26, driven by international medical cannabis growth, while the company exited low-margin Canadian consumer and plant propagation businesses. Adjusted EBITDA improved to $53.8M, but net loss from continuing operations was $(58.6)M. Material weakness in internal contr… 
Read More
ACB: International cannabis growth drove revenue gains, but net loss rose and internal control weaknesses remain
ByPot Shop News
June 11, 2026